Loading insider details...
Beta
Latest Form 4 (Aug 27, 2026): Grant/Award of 6,662 ANIP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 27, 2026 | ANI PHARMACEUTICALS INC (ANIP) | Grant/Award | 6,662 | n/a |
| Jun 11, 2024 | ACELYRIN, Inc. (SLRN) | Grant/Award | 92,158 | n/a |
| Feb 16, 2024 | Neumora Therapeutics, Inc. (NMRA) | Grant/Award | 80,000 | n/a |
| Sep 20, 2023 | Neumora Therapeutics, Inc. (NMRA) | Purchase | 15,000 | $189.4K |
| May 18, 2022 | AbbVie Inc. (ABBV) | Exercise/Conversion | 83,960 | $4.61M |
| Mar 2, 2022 | AbbVie Inc. (ABBV) | Sale | 15,733 | $2.31M |
| Mar 1, 2022 | AbbVie Inc. (ABBV) | Tax Withholding | 30,156 | $4.51M |
| Feb 22, 2022 | AbbVie Inc. (ABBV) | Grant/Award | 36,673 | n/a |
| Sep 10, 2021 | AbbVie Inc. (ABBV) | Gift | 30,000 | n/a |
| Mar 3, 2021 | AbbVie Inc. (ABBV) | Tax Withholding | 22,833 | $2.46M |